This small molecule inhibitor selectively targets IL-17A, a key cytokine in inflammatory pathways. It is a valuable research tool for studying autoimmune diseases such as psoriasis, rheumatoid arthritis, and multiple sclerosis in both cellular assays and preclinical animal models.